Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sanjivani Paranteral Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹154.00 |
|---|---|
| Day's Range | ₹144.00 - ₹154.80 |
| Open | ₹145.50 |
| 52 Week Range | ₹126.00 - ₹268.80 |
| Volume | 27,671 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 42.61 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 26.40 |
| TTM EPS (₹) | 5.52 |
| P/E Ratio | 35.17 |
| Book Value(₹) | 3.71 |
| PAT Margin (%) | 11.13 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 29.18 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 181.81 | 700.99 |
| Expenses | N/A | N/A |
| PBT | 26.61 | 103.6 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 21.94 | 81.02 |
About Sanjivani Paranteral Ltd.
| Founded | 1994 |
|---|---|
| Managing Director | Ashwani Khemka |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,46,792.16 | 1,872.60 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,151.98 | 6,562.25 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,914.73 | 4,628.00 | 3,171.90 - 3,171.90 |
| Apollo Hospitals Enterprise Ltd. | 1,23,557.75 | 8,663.85 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,353.96 | 1,453.50 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,12,681.23 | 1,376.30 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,09,875.05 | 1,121.45 | 835.50 - 835.50 |
| Max Healthcare Institute Ltd. | 1,09,280.68 | 1,150.75 | 903.00 - 903.00 |
| Lupin Ltd. | 1,07,090.72 | 2,406.30 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,01,632.12 | 2,480.35 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Sanjivani Paranteral informs about audio recording of earnings call
FDC informs about disclosures
Smruthi Organics informs about closure of trading window
Smruthi Organics has informed that the ‘Trading Window’ pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons pursuant to Regulation 9(1) and schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) Regulations, 2018, will remain closed with effect from Wednesday 01st July, 2026 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the first quarter ended June 30 ,2026. The date of Meeting of the Board of Directors of the Company, to approve the Un-Audited Financial Results of the Company for the first quarter ended June 30, 2026 will be informed in due course. All Insiders of the Company are requested to take note of this intimation and not to deal with / purchase or sale of the Company's securities during the Window Closure period.
The above information is a part of company’s filings submitted to BSE.
Alkem Laboratories informs about updates on acquisition
In continuation of its earlier intimations dated 13th February, 2026 and 06th March, 2026, wherein the Stock Exchanges were informed that Alkem Medtech, a wholly owned subsidiary of the Company in India (‘Alkem Medtech’), intends to acquire at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG(‘Occlutech’), a company incorporated in Switzerland and had executed Share Purchase Agreement with the selling shareholders of Occlutech respectively. In this regard, Alkem Laboratories has informed that on 26th June, 2026, Alkem Medtech has executed First Supplementary Agreement to Share Purchase Agreement dated 6th March, 2026 with the selling shareholders of Occlutech. A copy of this disclosure will be made available on the Company’s website in accordance with Regulation 30(8) of the SEBI LODR Regulations.
The above information is a part of company’s filings submitted to BSE.
FDC informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sanjivani Paranteral Ltd. is ₹154.00 as of 2026-06-29.
The market capitalisation of Sanjivani Paranteral Ltd. is ₹179.17 as of 2026-06-25.
The 1-year return of Sanjivani Paranteral Ltd. is -61.05% as of 2025-06-27.
The P/E ratio of Sanjivani Paranteral Ltd. is 35.17 as of 2026-06-29.
The 52-week high and low of Sanjivani Paranteral Ltd. are ₹268.80 and ₹126.00, respectively, as of 2026-06-29.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
